CNS Pharmaceuticals (CNSP) Director Michal Fisher Buys 2,000 Shares

What Happened
Michal Fisher, a director of CNS Pharmaceuticals, purchased 2,000 shares on May 18, 2026, at $5.00 per share for a total cost of $10,000. The transaction is reported as a purchase (transaction code P), which is generally more informative to investors than routine insider sales, though no motive is disclosed.

Key Details

• Transaction date: 2026-05-18
• Transaction type: Purchase (code P) — open market or private purchase (Form 4 lists P)
• Price per share: $5.00
• Shares acquired: 2,000
• Total value: $10,000
• Shares owned after transaction: Not specified in the provided filing
• Filing date / accession: Form 4 filed 2026-08-18 (Accession No. 0001683168-26-006553)
• Timeliness: Filing appears late (transaction reported May 18 but Form 4 filed Aug 18). Late filings delay public visibility and may warrant investor attention.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other footnotes noted in the summary provided.

Context
Insider purchases by company directors can signal confidence, but this is a relatively small ($10k) transaction and should be considered alongside company fundamentals and other insider activity. Because the Form 4 was filed late and the filing does not disclose post-transaction holdings or a trading plan, investors should treat this as a data point rather than a clear endorsement.